^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

GS-4528

i
Other names: GS-4528
Associations
Trials
Company:
Gilead
Drug class:
IL-2 stimulant
Related drugs:
Associations
Trials
2ms
Study of GS-4528 in Adults With Solid Tumors (clinicaltrials.gov)
P1, N=182, Recruiting, Gilead Sciences | N=132 --> 182
Enrollment change • Combination therapy • Metastases
|
Yutuo (zimberelimab) • GS-4528
over1year
Study of GS-4528 in Adults With Solid Tumors (clinicaltrials.gov)
P1, N=132, Recruiting, Gilead Sciences | Not yet recruiting --> Recruiting
Enrollment open • Combination therapy • Metastases
|
Yutuo (zimberelimab) • GS-4528